Skip to main content
Equibles

LAZARD ASSET MANAGEMENT LLC

Position in RXRX — Recursion Pharmaceuticals, Inc.

CIK 1207017 NEW YORK, NY
Back to RXRX Full portfolio

Position in RXRX

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$2,541,027
+$1,310,688 QoQ
Shares Held
692,378
+72.8% QoQ
Ownership
0.129%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#46
of 344 holders
Holding Since
Dec 2021
19 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in RXRX Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

LAZARD ASSET MANAGEMENT LLC holds $404,338,249 across 60 Biotechnology names. RXRX ranks #26 (0.6% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 ARGX
Argenx SE
 131,996 $122,461,928
2 VRTX
Vertex Pharmaceuticals Inc / Ma
 93,287 $46,338,451
3 ONC
BeOne Medicines Ltd.
 90,348 $25,746,469
4 REGN
Regeneron Pharmaceuticals, Inc.
 36,910 $23,014,861
5 BMRN
Biomarin Pharmaceutical Inc
 350,397 $20,049,716
6 EXEL
Exelixis, Inc.
 343,029 $18,664,207
7 JAZZ
Jazz Pharmaceuticals plc
 69,588 $16,768,620
8 INCY
Incyte Corp
 136,684 $15,494,498

All Filings in RXRX

Export CSV
19 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $2,541,027 692,378
2026-03-31 $1,230,339 400,762
2025-12-31 $1,717,824 420,006
2025-09-30 $2,416,400 495,164
2025-06-30 $2,046,081 404,364
2025-03-31 $2,677,470 506,138
2024-12-31 $3,757,546 555,850
2024-09-30 $4,232,809 642,308
2024-06-30 $3,931,185 524,158
2024-03-31 $2,798,259 280,668
2023-12-31 $3,664,952 371,699
2023-09-30 $2,562,933 335,024
2023-06-30 $2,578,068 345,123
2023-03-31 $2,304,751 345,540
2022-12-31 $1,263,738 163,909
2022-09-30 $3,236,815 304,212
2022-06-30 $2,357,417 289,609
2022-03-31 $1,352,695 188,924
2021-12-31 $2,456,167 143,384